.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Frank’s mix in July 2026 tilted heavily to Oil at 73.38% share, with Oil up 2.34% year over year but down 0.59% month over month, while Capsules held 26.58% share with a 21.52% year-over-year decline and a 4.02% month-over-month dip; Edible was negligible at 0.04% share with a 49.40% year-over-year drop and no month-over-month read. Against a brand-level year-over-year sales change of -5.40% and an average price up 2.59% to $28.85, the combination of resilient Oil volume and contracting Capsules indicates the portfolio is leaning into Oil to stabilize top-line, implying concentration risk even as rank 5 in Oil in British Columbia anchors visibility.
The pattern suggests Frank’s positioning is increasingly defined by Oil, where a 2.34% year-over-year lift paired with a 0.59% month-over-month softness can absorb part of the 21.52% year-over-year contraction in Capsules and the 4.02% month-over-month drop there; holding rank 5 in Oil in British Columbia while Oil commands 73.38% of internal sales concentrates equity in one aisle. With Capsules now just 26.58% of mix and Edible at 0.04% amid a 49.40% year-over-year decline, incremental gains in Oil share or price carry outsized impact on July 2026 outcomes, implying the brand’s near-term growth ceiling is tied to Oil execution rather than category breadth.
Competitive Landscape
Frank sits at #6 in ON Oil in July 2026, improving 3 ranks YoY from #9 and holding steady versus 3 months ago at #6, while the category leader Mod advanced from #2 to #1 with +11.5% YoY sales and Redecan slipped from #1 to #2 with -26.8% YoY sales; at the same time, ufeelu rose from #6 to #5 with +15.5% YoY sales and MediPharm Labs held #3 with -4.6% YoY sales, indicating that upward mobility is tied to positive momentum while flat or negative growth risks share loss. The pattern implies Frank’s climb to a peak rank of #6 in July 2026 alongside stability at #6 over the last 3 months positions it on the cusp of the top 5, but further rank gains likely require outperforming ufeelu’s +15.5% and avoiding Redecan-like declines, signaling a pivot point between consolidation and breakthrough.
Notable Products
CBD 100 Oil (30ml) posted the steepest decline in July 2026, dropping 59% month over month while still holding rank 1, whereas CBD Capsules 30-Pack (1500mg CBD) slid 4% MoM at rank 2. Two of the top three SKUs are non-edible formats (Oil and Capsules), indicating a tilt away from edibles despite CBD Lemon Gummies 30-Pack (1500mg CBD) entering at rank 3 with negligible volume at $99. The juxtaposition of a 59% MoM fall at the category leader and a modest 4% MoM dip in the runner-up implies reliance on legacy formats with weakening velocity at the top, pointing to a need for mix recalibration toward steadier capsules or emerging gummies rather than concentration in a single flagship oil.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
